4.2 Article

Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

The impact of the CYP2D6-polymorphism on dose recommendations for current antidepressants

Norbert Thuerauf et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2006)

Review Biochemistry & Molecular Biology

Cytochrome P450 pharmacogenetics and cancer

C Rodriguez-Antona et al.

ONCOGENE (2006)

Article Hematology

Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias

M Aydin-Sayitoglu et al.

AMERICAN JOURNAL OF HEMATOLOGY (2006)

Review Public, Environmental & Occupational Health

Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: A HuGE review

LF Masson et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)

Article Biochemistry & Molecular Biology

Cytochrome P4501A1 polymorphisms in the Amerindian and mestizo populations of Mexico

JM Fragoso et al.

CELL BIOCHEMISTRY AND FUNCTION (2005)

Article Biochemistry & Molecular Biology

CYP2D6 and CYP1A1 mutations in the Turkish population

M Aydin et al.

CELL BIOCHEMISTRY AND FUNCTION (2005)

Review Pharmacology & Pharmacy

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

UM Zanger et al.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)

Review Biochemistry & Molecular Biology

Cytochrome P450 gene polymorphism and cancer

JAG Agúndez

CURRENT DRUG METABOLISM (2004)

Review Medicine, General & Internal

Elderly patients with acute myeloid leukemia: Characteristics in biology, patients, and treatment

U Wedding et al.

MEDIZINISCHE KLINIK (2003)

Article Oncology

GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk

SJ Lewis et al.

CANCER LETTERS (2002)